| Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25-year single-institution experience JM Cloyd, MHG Katz, L Prakash, GR Varadhachary, RA Wolff, RT Shroff, ... Journal of Gastrointestinal Surgery 21 (1), 164-174, 2017 | 143 | 2017 |
| Response and survival associated with first-line FOLFIRINOX vs gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma G Perri, L Prakash, W Qiao, GR Varadhachary, R Wolff, D Fogelman, ... JAMA surgery 155 (9), 832-839, 2020 | 139 | 2020 |
| Association of clinical factors with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma JM Cloyd, H Wang, ME Egger, CWD Tzeng, LR Prakash, A Maitra, ... JAMA surgery 152 (11), 1048-1056, 2017 | 89 | 2017 |
| Radiographic and serologic predictors of pathologic major response to preoperative therapy for pancreatic cancer G Perri, L Prakash, H Wang, P Bhosale, GR Varadhachary, R Wolff, ... Annals of surgery 273 (4), 806-813, 2021 | 80 | 2021 |
| Angiogenin/ribonuclease 5 is an EGFR ligand and a serum biomarker for erlotinib sensitivity in pancreatic cancer YN Wang, HH Lee, CK Chou, WH Yang, Y Wei, CT Chen, J Yao, JL Hsu, ... Cancer Cell 33 (4), 752-769. e8, 2018 | 74 | 2018 |
| Superior mesenteric artery margin of posttherapy pancreaticoduodenectomy and prognosis in patients with pancreatic ductal adenocarcinoma L Liu, MH Katz, SM Lee, LK Fischer, L Prakash, N Parker, H Wang, ... The American journal of surgical pathology 39 (10), 1395-1403, 2015 | 63 | 2015 |
| Active surveillance for adverse events within 90 days: the standard for reporting surgical outcomes after pancreatectomy L Schwarz, M Bruno, NH Parker, L Prakash, Y Mise, JE Lee, JN Vauthey, ... Annals of surgical oncology 22 (11), 3522-3529, 2015 | 63 | 2015 |
| Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma JM Cloyd, CH Crane, EJ Koay, P Das, S Krishnan, L Prakash, RA Snyder, ... Cancer 122 (17), 2671-2679, 2016 | 62 | 2016 |
| Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy JM Cloyd, GM Nogueras-González, LR Prakash, MQB Petzel, NH Parker, ... Journal of Gastrointestinal Surgery 22 (4), 703-712, 2018 | 52 | 2018 |
| Preoperative chemoradiation for pancreatic adenocarcinoma does not increase 90-day postoperative morbidity or mortality JW Denbo, ML Bruno, JM Cloyd, L Prakash, JE Lee, M Kim, CH Crane, ... Journal of Gastrointestinal Surgery 20 (12), 1975-1985, 2016 | 51 | 2016 |
| Pancreatic neuroendocrine tumors G Perri, LR Prakash, MHG Katz Current opinion in gastroenterology 35 (5), 468-477, 2019 | 47 | 2019 |
| Postoperative chemotherapy benefits patients who received preoperative therapy and pancreatectomy for pancreatic adenocarcinoma G Perri, L Prakash, W Qiao, GR Varadhachary, R Wolff, D Fogelman, ... Annals of surgery 271 (6), 996-1002, 2020 | 43 | 2020 |
| Role of fluorouracil, doxorubicin, and streptozocin therapy in the preoperative treatment of localized pancreatic neuroendocrine tumors L Prakash, P Bhosale, J Cloyd, M Kim, N Parker, J Yao, A Dasari, ... Journal of Gastrointestinal Surgery 21 (1), 155-163, 2017 | 43 | 2017 |
| Selective perioperative administration of pasireotide is more cost-effective than routine administration for pancreatic fistula prophylaxis JW Denbo, RS Slack, M Bruno, JM Cloyd, L Prakash, JB Fleming, MP Kim, ... Journal of Gastrointestinal Surgery 21 (4), 636-646, 2017 | 42 | 2017 |
| Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients C Mohindroo, M Hasanov, JE Rogers, W Dong, LR Prakash, S Baydogan, ... Cancer medicine 10 (15), 5041-5050, 2021 | 41 | 2021 |
| Influence of preoperative therapy on short-and long-term outcomes of patients with adenocarcinoma of the ampulla of Vater JM Cloyd, H Wang, M Overman, J Zhao, J Denbo, L Prakash, MP Kim, ... Annals of Surgical Oncology 24 (7), 2031-2039, 2017 | 37 | 2017 |
| After pancreatectomy, the “90 days from surgery” definition is superior to the “30 days from discharge” definition for capture of clinically relevant readmissions Y Mise, RW Day, JN Vauthey, KW Brudvik, L Schwarz, L Prakash, ... Journal of Gastrointestinal Surgery 20 (1), 77-84, 2016 | 36 | 2016 |
| Role and operative technique of portal venous tumor thrombectomy in patients with pancreatic neuroendocrine tumors L Prakash, JE Lee, J Yao, P Bhosale, A Balachandran, H Wang, ... Journal of Gastrointestinal Surgery 19 (11), 2011-2018, 2015 | 32 | 2015 |
| Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge TE Newhook, EA Vega, TJ Vreeland, L Prakash, WL Dewhurst, ML Bruno, ... Surgery 167 (2), 442-447, 2020 | 31 | 2020 |
| Benefit of gemcitabine/nab-paclitaxel rescue of patients with borderline resectable or locally advanced pancreatic adenocarcinoma after early failure of FOLFIRINOX TJ Vreeland, F McAllister, S Javadi, LR Prakash, DR Fogelman, L Ho, ... Pancreas 48 (6), 837, 2019 | 28 | 2019 |
